Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2326 AL 2340

The digital signature of emergent tremor in Parkinson's disease

Bronte-Stewart H, Gala A, Wilkins K, Pettruci M, Kehnemouyi Y, Velisar A, Trager M.

Res Sq [Preprint]. 2023 Oct 27:rs.3.rs-3467667. doi: 10.21203/rs.3.rs-3467667/v1.

SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein

Chesney AD, Maiti B, Hansmann UHE.

bioRxiv [Preprint]. 2023 May 8:2023.05.06.539715. doi: 10.1101/2023.05.06.539715.

Spectral features of resting-state EEG in Parkinson's Disease: A multicenter study using functional data analysis

Jaramillo-Jimenez A, Tovar-Rios DA, Ospina JA, Mantilla-Ramos YJ, Loaiza-López D, Henao Isaza V, Zapata Saldarriaga LM, Cadavid Castro V, Suarez-Revelo JX, Bocanegra Y, Lopera F, Pineda-Salazar DA, Tobón Quintero CA, Ochoa-Gomez JF, Borda MG, Aarsland D, Bonanni L, Brønnick K.

Clin Neurophysiol. 2023 Jul;151:28-40. doi: 10.1016/j.clinph.2023.03.363. Epub 2023 Apr 24.

Editorial: Insights in neuroenergetics, nutrition and brain health: 2023

Schurr A, Mokler DJ, Lee HG, Tasca CI.

Front Neurosci. 2023 Dec 13;17:1331872. doi: 10.3389/fnins.2023.1331872. eCollection 2023.

A labeled Clinical-MRI dataset of Nigerian brains

Wogu E, Filima P, Caron B, Levitas D, Herholz P, Leal C, Mehboob MF, Hayashi S, Akintoye S, Ogoh G, Godwin T, Eke D, Pestilli F.

ArXiv [Preprint]. 2023 Nov 8:arXiv:2311.04425v1.

1.3 Staging Parkinson's disease: early versus advanced criteria

Antonini A.

In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.

Outcome of deep brain stimulation in autosomal recessive monogenic mutations in young onset Parkinson's Disease

Kashyap M, Kola S, Yaranagula SD, Alugolu R, Kandadai RM, Borgohain R.

Parkinsonism Relat Disord. 2023 Jul;112:105486. doi: 10.1016/j.parkreldis.2023.105486. Epub 2023 Jun 8.

5.2 Future Parkinson's disease therapies with the potential for Parkinson's disease care

Fasano A, Devos D, Moreau C.

In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.

1.1 Parkinson's disease: aetiology and pathogenesis

Sulzer D.

In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.

Understanding cognitive changes in patients with Parkinson's disease using novel fiber quantification techniques

Vijayakumari AA, Mishra VR.

Parkinsonism Relat Disord. 2023 Oct;115:105857. doi: 10.1016/j.parkreldis.2023.105857. Epub 2023 Sep 14.

The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets

Outeiro TF, El-Agnaf OM.

Neurobiol Dis. 2023 Feb;177:105995. doi: 10.1016/j.nbd.2023.105995. Epub 2023 Jan 7.

Technological solution for the assessment and rehabilitation of visuo-cognition in Parkinson's disease

Das J, Morris R, Barry G, Celik Y, Godfrey A, McDonald C, Walker R, Vitorio R, Stuart S.

Expert Rev Med Devices. 2023 Apr;20(4):253-257. doi: 10.1080/17434440.2023.2192869. Epub 2023 Mar 23.

Healthy diet versus added sugars and unsaturated fatty acids in Parkinson's disease: Food for thought

Carrasco M, Camara A, Compta Y.

Parkinsonism Relat Disord. 2023 Oct;115:105865. doi: 10.1016/j.parkreldis.2023.105865. Epub 2023 Sep 20.

Editorial: Exercise-induced neuroplasticity in neurodegeneration diseases

Yu L, Almeida QJ, Silva AF, He L.

Front Neurosci. 2023 Sep 29;17:1296291. doi: 10.3389/fnins.2023.1296291. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias